ASCO: Bendamustine Held Superior to CHOP in Patients With Follicular, Indolent ... Cancer Network By Michael Kaufman | June 12, 2012 CHICAGO—The two-drug combination of bendamustine (Treanda) plus rituximab (Rituxan) is more effective and less toxic than the standard CHOP regimen—cyclophosphamide (Cytoxan), doxorubicin (Adriamycin), ... |
